m&a – DG Verifications & Stats

Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?

The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) on Dec. 5th, 2023. NYSE Group A version of this article first appeared in